Glycosylated hemoglobin and adverse events following elective coronary bypass revascularization

Journal Title: Current Research: Cardiology - Year 2018, Vol 5, Issue 2

Abstract

BACKGROUND: The aim of this retrospective study was to evaluate whether the level of preoperative glycosylated hemoglobin (HbA1c) is associated with incidence of major adverse events in patients undergoing elective coronary bypass surgery. METHODS: This was a retrospective observational study of 1,116 patients undergoing elective, isolated aortocoronary bypass surgery over a period of 5 years. Two groups were investigated, one with a preoperative HbA1c level ≤6.5% and the other with HbA1c superior to 6.5%. We used propensity modelling to calculate inverse probability of treatment weights (IPTW) for quantifying the association of increased HbA1c on outcome. RESULTS: According to inclusion criteria, 589 patients (mean age, 68.1 years; female:14%) were included in the analysis. HbA1c was ≤ 6.5% in 410 patients (69.6%) and was higher than 6.5% in 179 patients (30.4%). The in-hospital mortality rate before and after IPTW was not significantly higher in HbA1c>6.5% groups (1.0% vs. 3.4% p=0.054 and 1.1% vs. 3.5% p=0.076). After IPTW, the risk for major cardiovascular events was higher in patients with HbA1c>6.5%, odds ratio [OR] 3.19, confidence interval [CI] 1.48 to 6.87, p=0.003, and the risk for sternal infection OR 8.07 (CI 2.79-23.39, p<0.001), for sepsis OR 5.36 (CI 1.56 -18.46, p=0.008), and renal failure OR 3.16 (CI 1.12-8.88, p=0.03). CONCLUSION: Preoperatively, inadequately-treated diabetes mellitus that may be expressed as elevated HbA1c, which is directly associated with an elevated incidence of adverse events following elective coronary revascularization surgery.

Authors and Affiliations

Luca Koechlin, Ulrich Schurr, Brigitta Gahl, Martin Grapow, Oliver Reuthebuch, Denis A. Berdajs

Keywords

Related Articles

Management of anticoagulation in rate controlled atrial fibrillation: A three-step approach

Atrial Fibrillation is the most common type of cardiac arrhythmia managed in clinical practice. This condition predisposes patients to a multitude of potential complications that can be managed or prevented by medical or...

Long QT syndrome with torsade in a patient with atrial fibrillation taking antihistamines– Case report

OBJECTIVE: To report the case of a patient with long QT syndrome acquired after treatment of atrial fibrillation associated with the regular use of antihistamines. METHODS: The data of this work were obtained by reviewi...

Gated-SPECT myocardial perfusion imaging in women after acute coronary syndrome

OBJECTIVES: To assess the prognostic value of gated-SPECT myocardial perfusion imaging (MPI) in women after acute coronary syndrome (ACS), as well as to evaluate whether the intraventricular dyssynchrony shows any differ...

Incidence and associated risk factors of cancer in patients after infective endocarditis hospitalization: A propensity score matched analysis

BACKGROUND: The relationship between infective endocarditis (IE) and malignancies had been reported. However, cancer development is multifactorial and mortality is high in IE survivors. We aimed to estimate the absolute...

Pericardial lipoma: Diagnosed unexpectedly during heart failure investigation- Case Report

OBJECTIVE: To report the case of a patient with pericardial lipoma diagnosed unexpectedly during heart failure investigation with diagnosis definitive after surgery. METHODS: A review of medical records and analysis of...

Download PDF file
  • EP ID EP603121
  • DOI -
  • Views 49
  • Downloads 0

How To Cite

Luca Koechlin, Ulrich Schurr, Brigitta Gahl, Martin Grapow, Oliver Reuthebuch, Denis A. Berdajs (2018). Glycosylated hemoglobin and adverse events following elective coronary bypass revascularization. Current Research: Cardiology, 5(2), 18-22. https://europub.co.uk./articles/-A-603121